Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine

Detalles Bibliográficos
Autores principales: Gobbi, Federico, Buonfrate, Dora, Silva, Ronaldo, Martini, Davide, Bisoffi, Zeno, Piubelli, Chiara, Riccetti, Silvia, Sinigaglia, Alessandro, Barzon, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349413/
https://www.ncbi.nlm.nih.gov/pubmed/34371075
http://dx.doi.org/10.1016/j.jinf.2021.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349413/
https://www.ncbi.nlm.nih.gov/pubmed/34371075
http://dx.doi.org/10.1016/j.jinf.2021.08.008

Ejemplares similares